Humira and Panic attack - a phase IV clinical study of FDA data

Summary:

Panic attack is reported as a side effect among people who take Humira (adalimumab), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Enbrel, and have Psoriasis.

The phase IV clinical study analyzes which people have Panic attack when taking Humira. It is created by eHealthMe based on reports of 758,421 people who have side effects when taking Humira from the FDA, and is updated regularly.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,391 Humira users. Check the latest studies of Humira.

What is Panic attack?

Panic attack is found to be associated with 2,546 drugs and 2,067 conditions by eHealthMe. Check the latest studies of Panic attack.

On Oct, 23, 2025

758,421 people reported to have side effects when taking Humira.
Among them, 1,102 people (0.15%) have Panic attack.

Among these 1,102 people:

How long have people been on Humira when they have Panic attack? *

What is the gender of people who have Panic attack when taking Humira? *

female: 70.35 %
male: 29.65 %

What is the age of people who have Panic attack when taking Humira? *

What are other drugs people take besides Humira? *

What are other side effects people have besides Panic attack? *

Stress And Anxiety: 379 people, 34.39%
Dyspnea (difficult or laboured breathing): 184 people, 16.70%
Joint Pain: 167 people, 15.15%
Depression: 167 people, 15.15%
Pain: 166 people, 15.06%
Fatigue (feeling of tiredness): 163 people, 14.79%
Drug Ineffective: 161 people, 14.61%
Chest Pain: 160 people, 14.52%
Insomnia (sleeplessness): 132 people, 11.98%
Nausea (feeling of having an urge to vomit): 126 people, 11.43%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 193 people, 17.51%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 159 people, 14.43%
Stress And Anxiety: 134 people, 12.16%
Pain: 95 people, 8.62%
Depression: 77 people, 6.99%
High Blood Pressure: 70 people, 6.35%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 65 people, 5.90%
Ankylosing Spondylitis (type of arthritis affecting the spine): 62 people, 5.63%
Infection: 39 people, 3.54%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 33 people, 2.99%

* Approximation only. Some reports may have incomplete information.

Do you take Humira and have Panic attack?

- Check whether Panic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humira:

Humira (761,391 reports)

Panic attack treatments and more:

Panic attack (65,701 reports)

Common Humira side effects:

Browse all side effects of Humira:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Panic attack:

Browse all the drugs that are associated with Panic attack:

Panic attack (2,546 drugs)

Common conditions associated with Panic attack:

Depression aggravated: 4,389 reports
Antidepressant therapy: 4,383 reports
Depression: 4,380 reports
Anxiety aggravated: 3,663 reports
Apprehension: 3,662 reports
Pain: 2,123 reports
Alternative medicine - pain relief: 2,090 reports
Ms: 1,863 reports
Panic disorder: 1,831 reports
Panic attack: 1,767 reports

Browse all the conditions that are associated with Panic attack:

Panic attack (2,067 conditions)

Drugs similar to Humira and Panic attack :

Related publications that referenced our studies

Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.